X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3357) 3357
Publication (319) 319
Newspaper Article (117) 117
Newsletter (50) 50
Book Review (45) 45
Book Chapter (30) 30
Magazine Article (14) 14
Conference Proceeding (12) 12
Dissertation (6) 6
Data Set (3) 3
Trade Publication Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1710) 1710
humans (1625) 1625
index medicus (1536) 1536
chondroitin sulfate (1284) 1284
male (936) 936
female (848) 848
rats (617) 617
sulfates (538) 538
chondroitin (514) 514
neurosciences (458) 458
osteoarthritis (456) 456
glycosaminoglycans (411) 411
mice (399) 399
middle aged (371) 371
chondroitin sulfates - administration & dosage (352) 352
chondroitin sulfates - therapeutic use (330) 330
analysis (327) 327
pharmacology & pharmacy (325) 325
aged (322) 322
adult (317) 317
research (296) 296
glucosamine (283) 283
chondroitin sulfate proteoglycans (265) 265
treatment outcome (264) 264
proteins (253) 253
biochemistry & molecular biology (251) 251
knee osteoarthritis (238) 238
proteoglycans (231) 231
disease models, animal (230) 230
article (228) 228
rats, sprague-dawley (228) 228
care and treatment (225) 225
heparin (223) 223
cells, cultured (219) 219
central-nervous-system (218) 218
hyaluronic acid (218) 218
inflammation (215) 215
chondroitin sulfates - pharmacology (213) 213
in-vitro (213) 213
chondroitin sulfate proteoglycan (211) 211
extracellular matrix (205) 205
health aspects (205) 205
chondroitin sulfates - chemistry (200) 200
regeneration (195) 195
cell biology (194) 194
drug combinations (194) 194
rheumatology (192) 192
spinal cord injury (189) 189
medicine (185) 185
physiological aspects (184) 184
cartilage (183) 183
time factors (180) 180
chondroitin sulfate proteoglycans - metabolism (178) 178
collagen (178) 178
research article (178) 178
extracellular-matrix (175) 175
double-blind (172) 172
expression (171) 171
chondroitin sulfates - metabolism (169) 169
osteoarthritis - drug therapy (169) 169
arthritis (168) 168
enzymes (166) 166
rabbits (162) 162
spinal cord injuries (162) 162
surgery (161) 161
spinal-cord-injury (160) 160
sulfate (156) 156
glucosamine - therapeutic use (155) 155
rats, wistar (154) 154
chondroitin sulfates (151) 151
dietary supplements (150) 150
administration, oral (149) 149
immunohistochemistry (149) 149
dose-response relationship, drug (147) 147
multidisciplinary sciences (146) 146
functional recovery (143) 143
heparin - adverse effects (142) 142
neurons (141) 141
dermatan sulfate (139) 139
glycosaminoglycans - metabolism (139) 139
medicine, research & experimental (138) 138
cancer (137) 137
rodents (136) 136
pain (134) 134
orthopedics (132) 132
cells (129) 129
hyaluronic acid - administration & dosage (126) 126
hyaluronic-acid (125) 125
gene expression (124) 124
neurite outgrowth (122) 122
nervous system (120) 120
hematology (119) 119
glucosamine - administration & dosage (118) 118
in-vivo (118) 118
nerve regeneration - physiology (118) 118
drug delivery systems (117) 117
osteoarthritis, knee - drug therapy (117) 117
axonal regeneration (116) 116
glial scar (116) 116
molecular weight (116) 116
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3416) 3416
German (33) 33
Russian (30) 30
French (26) 26
Japanese (17) 17
Spanish (8) 8
Chinese (5) 5
Italian (5) 5
Polish (4) 4
Arabic (1) 1
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Portuguese (1) 1
Romanian (1) 1
Serbian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
MINERVA MEDICA, ISSN 0026-4806, 10/2019, Volume 110, Issue 5, pp. 419 - 424
BACKGROUND. Osteoarthritis (OA) is a common worldwide disease induced by a wide range of biochemical processes, mainly inflammation and degradation of... 
CYTOKINES | NAFLD | COX-2 | OMEGA-3-FATTY-ACIDS | GUT MICROBIOTA | INDUCTION | Probiotics | MEDICINE, GENERAL & INTERNAL | Gastrointestinal microbiome | DISEASE | GENES | Chondroitin sulfates | ARTICULAR CHONDROCYTES | ANIMAL-MODEL | Osteoarthritis
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e24S - e43S
This article describes the pharmacology of approved parenteral anticoagulants. These include the indirect anticoagulants, unfractionated heparin (UFH),... 
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Heparitin Sulfate - adverse effects | United States | Humans | Thrombin - antagonists & inhibitors | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Pipecolic Acids - administration & dosage | Chondroitin Sulfates - adverse effects | Societies, Medical | Pipecolic Acids - adverse effects | Heparitin Sulfate - administration & dosage | Polysaccharides - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Dermatan Sulfate - administration & dosage | Dermatan Sulfate - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Evidence-Based Medicine | Recombinant Proteins - administration & dosage | Antithrombins - agonists | Chondroitin Sulfates - administration & dosage | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Thrombosis - drug therapy | Heparin, Low-Molecular-Weight - administration & dosage | Infusions, Intravenous | Practice Guidelines as Topic | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2013, Volume 110, Issue 33, pp. 13582 - 13587
Sulfate-reducing bacteria (SRB) colonize the guts of ~50% of humans. We used genome-wide transposon mutagenesis and insertion-site sequencing, RNA-Seq, plus... 
Datasets | Ammonia | Microbiota | Polysaccharides | Gnotobiotics | Diet | Hydrogen | Humans | Mice | Sulfates | Hydrogen sulfide | Hydrogenotrophs | Artificial human gut microbiota/microbiome | Microbial foodwebs | Determinants of microbial fitness | hydrogenotrophs | CHONDROITIN SULFATE | RAT | MULTIDISCIPLINARY SCIENCES | ULCERATIVE-COLITIS | COLON | SULFIDE | microbial foodwebs | hydrogen sulfide | FATTY-ACID OXIDATION | ANAEROBIC-BACTERIA | BACTEROIDES-THETAIOTAOMICRON | DESULFOVIBRIO-VULGARIS HILDENBOROUGH | artificial human gut microbiota/microbiome | determinants of microbial fitness | CONTINUOUS-CULTURE | Hydrogen Sulfide - metabolism | Chondroitin Sulfates - metabolism | Gas Chromatography-Mass Spectrometry | Species Specificity | Gastrointestinal Tract - microbiology | Bromodeoxyuridine | Chondroitin Sulfates - pharmacology | DNA Primers - genetics | Desulfovibrio - genetics | Sequence Analysis, DNA | Genetic Vectors - genetics | Chondroitin Sulfates - administration & dosage | Feces - microbiology | Animals | Mutagenesis | Desulfovibrio - drug effects | Desulfovibrio - metabolism | Mass Spectrometry | DNA Transposable Elements - genetics | Dietary Supplements | Desulfovibrio - growth & development | Physiological aspects | Sulfate-reducing bacteria | Genetic aspects | Research | Bacterial genetics | Microbial metabolism | Index Medicus | Biological Sciences | artificial human gut microbiota | microbiome
Journal Article
Journal Article
Carbohydrate Polymers, ISSN 0144-8617, 06/2019, Volume 214, pp. 131 - 141
Progress at elimination of malaria is limited by the challenges of reaching large rural population and ensuring patient adherence to adequate pharmacologic... 
Sustained release | Chondroitin sulfate | Meshy gel | Malaria | Ivermectin | PHASE-SEPARATION GEL | HYDROGELS | POLYMER SCIENCE | GLYCOSAMINOGLYCANS | EFFICACY | DRUG-DELIVERY | CHEMISTRY, ORGANIC | RELEASE | TRANSMISSION | THERAPY | LOW-TOXICITY | CHEMISTRY, APPLIED | Amines - chemistry | Viscosity | Gels - chemical synthesis | Rats, Wistar | Drug Carriers - administration & dosage | Delayed-Action Preparations - chemistry | Male | Drug Carriers - chemistry | Delayed-Action Preparations - administration & dosage | Insecticides - administration & dosage | Viscoelastic Substances - chemistry | Ethanol - adverse effects | Amines - administration & dosage | Delayed-Action Preparations - chemical synthesis | Gels - chemistry | Skin - pathology | Models, Theoretical | Antimalarials - pharmacokinetics | Gels - administration & dosage | Viscoelastic Substances - chemical synthesis | Ivermectin - pharmacokinetics | Drug Carriers - chemical synthesis | Amines - chemical synthesis | Chondroitin Sulfates - chemistry | Culicidae - drug effects | Chondroitin Sulfates - administration & dosage | Ivermectin - administration & dosage | Injections | Animals | Antimalarials - administration & dosage | Ethanol - chemistry | Drug Liberation | Viscoelastic Substances - administration & dosage | Mice | Chondroitin Sulfates - chemical synthesis | Insecticides - pharmacokinetics | Drugs | Drug delivery systems | Analysis | Blood lipids | Sulfates | Pharmaceutical industry | Patient compliance | Chondroitin | Vehicles
Journal Article
Journal Article